Continuous-infusion oxacillin for the treatment of burn wound cellulitis

Surgical Infections

Volumn 10, Issue 1, 2009, Pages 41-45

  Schuster, Kevin M ^a   Wilson, David ^a   Schulman, Carl I ^b   Pizano, Louis R ^b   Ward, C Gillon ^b   Namias, Nicholas ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; OXACILLIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; BURN; CELLULITIS; COHORT ANALYSIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KAPLAN MEIER METHOD; LEUKOCYTOSIS; MALE; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BURNS; CELLULITIS; COHORT STUDIES; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KAPLAN-MEIERS ESTIMATE; LEUKOCYTOSIS; MALE; MIDDLE AGED; OXACILLIN; RETROSPECTIVE STUDIES; VANCOMYCIN; YOUNG ADULT;

EID: 67649532096     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2007.081     Document Type: Article

References (14)

1. Pruitt BA, McManus AT, Kim SH, Goodwin CW. Burn wound infections: Current status. World J Surg 1998;22:135-145. (Pubitemid 28065179)
2. Durtschi MB, Orgain C, Counts GW, Heimbach DM. A prospective study of prophylactic penicillin in acutely burned hospitalized patients. J Trauma 1982;22:11-14. (Pubitemid 12165509)
3. Cook N. Methicillin resistant Staphylococcus aureus versus the burned patient. Burns 1998;24:91-98. (Pubitemid 28233906)
4. Fong J, Wood F, Fowler B. A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: Comparative patient audits. Burns 2005;31:562-567. (Pubitemid 40905213)
5. Larkin JM, Moylan JA. The role of prophylactic antibiotics in burn care. Am Surg 1976;42:247-250.
6. Kasiakou SK, Sermaides GJ, Michalopoulos A, et al. Continuous versus intermittent intravenous administration of antibiotics: A meta-analysis of randomised controlled trials. Lancet Infect Dis 2005;5:581-589. (Pubitemid 41196757)
7. Drusano GL. Human pharmacodynamics of beta-lactams, aminoglycosides and their combination. Scand J Infect Dis 1991;74(Suppl):235-248.
8. Craig WA, Ebert SC. Continuous infusion of beta-lactam antibiotics. Antimicrob Agents Chemother 1992;36:2577-2583.
9. Georges B, Archambaud M, Saivin S, et al. Continuous versus intermittent cefepime infusion in critical care: Preliminary results. Pathol Biol (Paris) 1999;47:483-485. (Pubitemid 29284040)
10. Hanes SD, Wood GC, Herring V, et al. Intermittent and continuous ceftazidime infusion for critically ill trauma patients. Am J Surg 2000;179:436-440.
11. McNabb JJ, Nightingale CH, Quintiliani R, Nicolau DP. Cost-effectiveness of ceftazadime by continuous infusion versus intermittent infusion for nosocomial pneumonia. Pharmacotherapy 2001;21:549-555. (Pubitemid 32411052)
12. Angus BJ, Smith MD, Suputtamongkol Y, et al. Pharmacokinetic- pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis. Br J Clin Pharmacol 2000;49:445-452. (Pubitemid 30229448)
13. Buijk SL, Gyssens IC, Mouton JW, et al. Phamacokinetics of ceftazidime in serum and peritoneal exudates during continuous versus intermittent administration to patients with severe intra-abdominal infections. J Antimicrob Chemother 2002;49:121-128. (Pubitemid 34100654)
14. Pruitt BA Jr, O'Neill JA Jr, Moncrief JA, Lindberg RB. Successful control of burn wound sepsis. JAMA 1968;203:1054.